Unibest

About

United, We Can Be the Best!

Established in 2003, a global enterprise built upon the core values of United, Networked, Innovative, Beyond, Efficient, Satisfied, and Technological.

Trading

Pharmaceutical APIs, intermediates, and Biopharma products with a major presence in European and American markets, backed by our own CDMO facilities.

Licensing

In-licensing and out-licensing of drug candidates and finished products — covering innovative drugs, generic drugs, and chemical intermediates.

Global Network

Business centers across Asia, Europe, North America, and Oceania, cultivating long-term partnerships with major multinational pharmaceutical corporations.

About Unibest
0+Partners
0+Projects
0+Audits
0+Years Experience

Values

Every letter of UNIBEST stands for a principle we live by.

Satisfied
Efficient
Technological
Networked
Innovative
Beyond
United

History

Two decades of relentless growth.

2003

Established Unibest Industrial, starting with chemical trading to lay the foundation for the supply chain.

2007

Founded Shanghai Unibest Biopharma, initiating a strategic upgrade to focus on independent technology R&D in the pharmaceutical sector.

2009

Invested in Shanghai Qinlong Chemical (CDMO base), completing the full industry chain layout and integrating R&D, production, and sales.

2012

Acquired a stake in Xi'an Caijing Opto-Electrical Science & Technology Co., Ltd., venturing into the field of pharmaceutical materials.

2013

Established Ningbo Advirtue Biomedical Technology Co., Ltd., focusing on early-stage biomedical projects.

2015

Invested in Guangzhou Taqing Environmental, supporting the green production transformation in the chemical and pharmaceutical industries.

2018

Invested in Shenzhen Aoqi Bio-Tech, developing a dual-track approach for improved new drugs and drug delivery systems.

2019

Focused on technological breakthroughs: Shanghai Unibest Biomedical for high-end intermediates, Zhejiang Tize Biomedical for AI drug design + continuous flow technology, Nanjing Daoyi Biomedical for large-molecule LNP delivery systems.

2022

Established SingaPharma Pte. Ltd. to build a platform for pharmaceutical import and licensing in the Asia-Pacific region.

2023

Established an Auckland business center in New Zealand, setting up a new overseas foothold for Asia-Pacific market expansion.

2024

Established business centers in Paris and New York, forming a dual-core structure in Europe and the U.S. to cover European market access and North American commercialization resources.

2025

Unibest's new global headquarters was unveiled, marking the beginning of a new chapter in the company's international expansion.

Team

The people driving Unibest's global vision.

Allan Ko

Allan Ko

Chairman

  • 25 years of experience in global chemical trade and biopharmaceutical investment
  • Founded Unibest and several other enterprises
  • Made strategic equity investments in multiple biopharmaceutical companies
  • Professor at the School of Pharmacy, Lanzhou University
  • Department of Economics and Management, Zhejiang University of Technology
  • CEIBS EMBA
John Ren

John Ren

General Manager

  • 21 years of experience in management, business operations, and portfolio listing
  • Senior Manager of Pharmaceutical Project Operations at Roche
  • Director of Technical Marketing, Fujifilm Wako Pharmaceutical
  • Founder of WuXi Biologics Suzhou Base (CMAB Pharmaceuticals)
  • Doctoral degree in Pharmaceutical Management from the University of Otago
  • Master of Pharmaceutical Science, University of Auckland
Steven Xia

Steven Xia

Vice President

  • Graduated from Zhejiang University in 1997
  • One of the three founders of Unibest
  • Over 20 years of working experience in the pharmaceutical industry
  • Has established cooperation with more than 20 globally renowned pharmaceutical companies
  • Has successfully expanded the business from Pharma to Biopharma
Wayne Gong

Wayne Gong

Vice President

  • Joined Unibest in 2009 and currently serves as one of the company's partners
  • Over 16 years of hands-on experience in the pharmaceutical industry
  • More than 8 years of business operations and team management at Fortune 500 companies
  • Leads the CDMO business for pharmaceutical intermediates
  • Master of Business Administration (MBA), Fudan University

What is ESG

Check what and how we do to build a better world.

ESG

Unibest believes everyone has the responsibility to take care of our beautiful planet. We consider Sustainable Development Goals (SDGs) everywhere within our reach.

How can we help you?

Receive insights into the latest events and regulatory updates

Sent directly to your email

Get industry insights and Unibest news here

Contact Us →